Molecular Tumor Board: 56 year-old female with Stage IIIC2 endometrial cancer, PD-L1 <1%, MSI-H, TMB-H
1 October 2023
Presented by:
Rebecca Previs, MD, MS
Labcorp Oncology, Director, Medical Affairs
Kyle Strickland, MD, PhD
Director, Medical Affairs
Sarabjot Pabla, PhD
Head of Clinical & Research Bioinformatics, Omniseq